The European Medicines Agency is set to decide whether to recommend EU marketing approval for 11 new medicines, including two ovarian cancer drugs and a lung cancer therapy.
The European Medicines Agency is set to decide whether to recommend EU marketing approval for 11 new medicines, including two ovarian cancer drugs and a lung cancer therapy.